2025
SJR Q2
JCR Q3 · 2,3
36 matched articles
SCIE
Journal detail
European Journal of Drug Metabolism and Pharmacokinetics
- Country
- Switzerland · Western Europe
- Type
- journal
- ISSN
-
0378796621070180
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,632
- Quartile Q2
- H-Index 52
- Cites/doc 2,39
- Docs (3y) 191
- Cites (3y) 504
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,3
- 5Y JIF 2,2
- JCI 0,53
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Pharmacology Q2
- Pharmacology (medical) Q2
Areas
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Pharmacology & Pharmacy
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,632 | 2,3 | 2,2 | 0,53 | Q3 | 52 |
| 2024 | Q2 | Q3 | 0,694 | 2,4 | 2,6 | 0,61 | Q3 | 50 |
| 2023 | Q3 | Q3 | 0,462 | 1,9 | 2,2 | 0,52 | Q3 | 50 |
| 2022 | Q2 | Q4 | 0,524 | 1,9 | 2,1 | 0,57 | Q3 | 50 |
| 2021 | Q2 | Q3 | 0,53 | 2,6 | 2,3 | 0,6 | Q3 | 50 |
| 2020 | Q2 | Q3 | 0,573 | 2,4 | 2,2 | 0,66 | Q3 | 50 |
| 2019 | Q3 | Q3 | 0,517 | 1,9 | 1,6 | 0,62 | Q3 | 50 |
| 2018 | — | Q4 | — | 1,5 | 1,5 | 0,6 | Q3 | — |
| 2017 | Q3 | Q4 | 0,338 | 1,4 | 1,2 | 0,53 | Q3 | 50 |
| 2016 | Q3 | Q4 | 0,345 | 1,4 | 1,4 | — | — | 50 |
| 2015 | Q3 | Q3 | 0,361 | 1,7 | 1,3 | — | — | 50 |
| 2014 | Q3 | Q3 | 0,42 | 1,6 | 1,2 | — | — | 50 |
| 2013 | Q2 | Q3 | 0,389 | 1,3 | 1 | — | — | 50 |
| 2012 | Q3 | Q4 | 0,264 | 0,9 | 0,8 | — | — | 50 |
| 2011 | Q3 | Q4 | 0,22 | 0,4 | 0,6 | — | — | 50 |
| 2010 | Q3 | Q4 | 0,327 | 0,4 | 0,6 | — | — | 50 |
| 2009 | — | Q4 | — | 0,7 | 0,6 | — | — | — |
| 2008 | — | Q4 | — | 0,7 | 0,6 | — | — | — |
| 2007 | — | Q4 | — | 0,6 | 0,6 | — | — | — |
| 2006 | — | Q4 | — | 0,5 | — | — | — | — |
| 2005 | — | Q4 | — | 0,6 | — | — | — | — |
| 2004 | — | Q4 | — | 0,4 | — | — | — | — |
| 2003 | — | Q4 | — | 0,5 | — | — | — | — |
| 2002 | — | Q4 | — | 0,3 | — | — | — | — |
| 2001 | — | Q4 | — | 0,4 | — | — | — | — |
| 2000 | — | Q4 | — | 0,5 | — | — | — | — |
| 1999 | — | Q4 | — | 0,4 | — | — | — | — |
| 1998 | — | Q3 | — | 0,6 | — | — | — | — |
| 1997 | — | Q4 | — | 0,6 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 226/356 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 195/352 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 231/354 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 224/278 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 200/279 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 201/276 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 201/271 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 221/267 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 221/261 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 206/257 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 176/255 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 178/255 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 187/256 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 213/261 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 243/261 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 234/252 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 205/237 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 193/219 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 193/205 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 186/199 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 176/193 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 174/187 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 171/185 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 176/188 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 174/186 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 161/181 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 154/175 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 131/178 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 125/157 |